Cortical and Subcortical Brain Atrophy Assessment Using Simple Measures on NCCT Compared with MRI in Acute Stroke

References

1. 1.↵
   1. Rabinstein AA,
   2. Albers GW,
   3. Brinjikji W, et al

   . Factors that may contribute to poor outcome despite good reperfusion after acute endovascular stroke therapy. Int J Stroke 2019;14:23–31 doi:10.1177/1747493018799979 pmid:30188259

   CrossRefPubMed
2. 2.↵
   1. Pedraza MI,
   2. de Lera M,
   3. Bos D, et al

   . Brain atrophy and the risk of futile endovascular reperfusion in acute ischemic stroke. Stroke 2020;51:1514–21 doi:10.1161/STROKEAHA.119.028511 pmid:32188368

   CrossRefPubMed
3. 3.↵
   1. Luijten SP,
   2. Compagne KC,
   3. van Es AC, et al

   . Brain atrophy and endovascular treatment effect in acute ischemic stroke: a secondary analysis of the MR CLEAN trial. Int J Stroke 2021 Oct 28. [Epub ahead of print] doi:10.1177/17474930211054964 pmid:34711105

   CrossRefPubMed
4. 4.↵
   1. Lauksio I,
   2. Lindström I,
   3. Khan N, et al

   . Brain atrophy predicts mortality after mechanical thrombectomy of proximal anterior circulation occlusion. J Neurointerv Surg 2021;13:415–20 doi:10.1136/neurintsurg-2020-016168 pmid:32620574

   Abstract/FREE Full Text
5. 5.↵
   1. Lamballais S,
   2. Zijlmans JL,
   3. Vernooij MW, et al

   . The risk of dementia in relation to cognitive and brain reserve. J Alzheimers Dis 2020;77:607–18 doi:10.3233/JAD-200264 pmid:32741820

   Abstract/FREE Full Text
6. 6.↵
   1. Fuchs TA,
   2. Benedict RH,
   3. Bartnik A, et al

   . Preserved network functional connectivity underlies cognitive reserve in multiple sclerosis. Hum Brain Mapp 2019;40:5231–41 doi:10.1002/hbm.24768 pmid:31444887

   CrossRefPubMed
7. 7.↵
   1. Yoon HJ,
   2. Kim SG,
   3. Kim SH, et al

   ; For the Alzheimer’s Disease Neuroimaing Initiative. Associations between brain reserve proxies and clinical progression in Alzheimer’s disease dementia. Int J Environ Res Public Health 2021;18:12159 doi:10.3390/ijerph182212159

   CrossRef
8. 8.↵
   1. Benali F,
   2. Singh N,
   3. Fladt J, et al

   . Brain frailty mediates the relationship between age and 90-day functional outcome after endovascular therapy: analysis of the Escape-NA1 trial. Stroke 2023;54(Suppl1):AWMP57 doi:10.1161/str.54.suppl_1.WMP57

   CrossRef
9. 9.↵
   1. Husseini NE,
   2. Katzan IL,
   3. Rost NS, et al

   ; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Hypertension; and Council on Lifestyle and Cardiometabolic Health. Cognitive impairment after ischemic and hemorrhagic stroke: a scientific statement from the American Heart Association/American Stroke Association. Stroke 2023;54:e272–91 doi:10.1161/STR.0000000000000430 pmid:37125534

   CrossRefPubMed
10. 10.↵
    1. Bigler ED

    . The clinical significance of cerebral atrophy in traumatic brain injury. Arch Clin Neuropsychol 1987;2:293–304 pmid:14589621

    CrossRefPubMed
11. 11.↵
    1. Caspers J,
    2. Heeger A,
    3. Turowski B, et al

    . Automated age- and sex-specific volumetric estimation of regional brain atrophy: workflow and feasibility. Eur Radiol 2021;31:1043–48 doi:10.1007/s00330-020-07196-8 pmid:32852588

    CrossRefPubMed
12. 12.↵
    1. Kaipainen AL,
    2. Pitkänen J,
    3. Haapalinna F, et al

    . A novel CT-based automated analysis method provides comparable results with MRI in measuring brain atrophy and white matter lesions. Neuroradiology 2021;63:2035–46 doi:10.1007/s00234-021-02761-4 pmid:34389887

    CrossRefPubMed
13. 13.↵
    1. Pasquier F,
    2. Leys D,
    3. Weerts JG, et al

    . Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 1996;36:268–72 doi:10.1159/000117270 pmid:8864706

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Koedam EL,
    2. Lehmann M,
    3. van der Flier WM, et al

    . Visual assessment of posterior atrophy development of an MRI rating scale. Eur Radiol 2011;21:2618–25 doi:10.1007/s00330-011-2205-4 pmid:21805370

    CrossRefPubMed
15. 15.↵
    1. Torisson G,
    2. van Westen D,
    3. Stavenow L, et al

    . Medial temporal lobe atrophy is underreported and may have important clinical correlates in medical inpatients. BMC Geriatr 2015;15:65 doi:10.1186/s12877-015-0066-4 pmid:26076825

    CrossRefPubMed
16. 16.↵
    1. van Zagten M,
    2. Kessels F,
    3. Boiten J, et al

    . Interobserver agreement in the assessment of cerebral atrophy on CT using bicaudate and Sylvian-fissure ratios. Neuroradiology 1999;41:261–64 doi:10.1007/s002340050743 pmid:10344510

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Kipps CM,
    2. Davies RR,
    3. Mitchell J, et al

    . Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale. Dement Geriatr Cogn Disord 2007;23:334–42 doi:10.1159/000100973 pmid:17374952

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Boldor N,
    2. Vaknin S,
    3. Myers V, et al

    . Reforming the MRI system: the Israeli National Program to shorten waiting times and increase efficiency. Isr J Health Policy Res 2021;10:57 doi:10.1186/s13584-021-00493-7 pmid:34663450

    CrossRefPubMed
19. 19.↵
    1. Frija G,
    2. Blažić I,
    3. Frush DP, et al

    . How to improve access to medical imaging in low- and middle-income countries? EClinicalMedicine 2021;38:101034 doi:10.1016/j.eclinm.2021.101034 pmid:34337368

    CrossRefPubMed
20. 20.↵
    1. Wattjes MP,
    2. Henneman WJ,
    3. van der Flier WM, et al

    . Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT. Radiology 2009;253:174–83 doi:10.1148/radiol.2531082262 pmid:19635835

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Ferguson KJ,
    2. Cvoro V,
    3. MacLullich AM, et al

    . Visual rating scales of white matter hyperintensities and atrophy: comparison of computed tomography and magnetic resonance imaging. J Stroke Cerebrovasc Dis 2018;27:1815–21 doi:10.1016/j.jstrokecerebrovasdis.2018.02.028 pmid:29576397

    CrossRefPubMed
22. 22.↵
    1. Lee SH,
    2. Oh CW,
    3. Han JH, et al

    . The effect of brain atrophy on outcome after a large cerebral infarction. J Neurol Neurosurg Psychiatry 2010;81:1316–21 doi:10.1136/jnnp.2009.197335 pmid:20650914

    Abstract/FREE Full Text
23. 23.↵
    1. Butzkueven H,
    2. Kolbe SC,
    3. Jolley DJ, et al

    . Validation of linear cerebral atrophy markers in multiple sclerosis. J Clin Neurosci 2008;15:130–37 doi:10.1016/j.jocn.2007.02.089 pmid:18068987

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Hill MD,
    2. Goyal M,
    3. Menon BK, et al

    ; ESCAPE-NA1 Investigators. Efficacy and Safety of Nerinetide for the Ttreatment of Acute Ischaemic Stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. Lancet 2020;395:878–87 doi:10.1016/S0140-6736(20)30258-0 pmid:32087818

    CrossRefPubMed
25. 25.↵
    1. Schmaranzer F,
    2. Kallini JR,
    3. Miller PE, et al

    . The effect of modality and landmark selection on MRI and CT femoral torsion angles. Radiology 2020;296:381–90 doi:10.1148/radiol.2020192723 pmid:32515680

    CrossRefPubMed
26. 26.↵
    1. Liao JJ

    . Sample size calculation for an agreement study. Pharm Stat 2010;9:125–32 doi:10.1002/pst.382 pmid:19507134

    CrossRefPubMed
27. 27.↵
    1. Zec S,
    2. Soriani N,
    3. Comoretto R, et al

    . High agreement and high prevalence: the paradox of Cohen’s Kappa. Open Nurs J 2017;11:211–18 doi:10.2174/1874434601711010211 pmid:29238424

    CrossRefPubMed
28. 28.↵
    1. Gwet KL

    . Computing inter-rater reliability and its variance in the presence of high agreement. Br J Math Stat Psychol 2008;61:29–48 doi:10.1348/000711006X126600 pmid:18482474

    CrossRefPubMed
29. 29.↵
    1. Gwet KL

    . Testing the difference of correlated agreement coefficients for statistical significance. Educ Psychol Meas 2016;76:609–37 doi:10.1177/0013164415596420 pmid:29795880

    CrossRefPubMed
30. 30.↵
    1. Wongpakaran N,
    2. Wongpakaran T,
    3. Wedding D, et al

    . A comparison of Cohen’s kappa and Gwet’s AC1 when calculating inter-rater reliability coefficients: a study conducted with personality disorder samples. BMC Med Res Methodol 2013;13:61 doi:10.1186/1471-2288-13-61 pmid:23627889

    CrossRefPubMed
31. 31.↵
    1. Landis JR,
    2. Koch GG

    . The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Schober P,
    2. Boer C,
    3. Schwarte LA

    . Correlation coefficients: appropriate use and interpretation. Anesth Analg 2018;126:1763–68 doi:10.1213/ANE.0000000000002864 pmid:29481436

    CrossRefPubMed
33. 33.↵
    1. Giavarina D

    . Understanding Bland Altman analysis. Biochem Med (Zagreb) 2015;25:141–51 doi:10.11613/BM.2015.015 pmid:26110027

    CrossRefPubMed
34. 34.↵
    1. Bland JM,
    2. Altman DG

    . Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307–10 pmid:2868172

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Park J,
    2. Goh DH,
    3. Sung JK, et al

    . Timely assessment of infarct volume and brain atrophy in acute hemispheric infarction for early surgical decompression: strict cutoff criteria with high specificity. Acta Neurochir (Wien) 2012;154:79–85 doi:10.1007/s00701-011-1178-z pmid:21979162

    CrossRefPubMed
36. 36.↵
    1. Benali F,
    2. Fladt J,
    3. Jaroenngarmsamer T, et al

    . Association of white matter disease with functional recovery and 90‐day outcome after EVT: beyond chronological age. Stroke Vasc Interv Neurol 2023;3:e000734 doi:10.1161/SVIN.122.000734

    CrossRef
37. 37.↵
    1. Bretzner M,
    2. Bonkhoff AK,
    3. Schirmer MD, et al

    ; MRI-GENIE and GISCOME Investigators and the International Stroke Genetics Consortium. Radiomics-derived brain age predicts functional outcome after acute ischemic stroke. Neurology 2023;100:e822–33 doi:10.1212/WNL.0000000000201596 pmid:36443016

    CrossRefPubMed
38. 38.↵
    1. Benali F,
    2. Fladt J,
    3. Jaroenngarmsamer T, et al

    . Association of brain atrophy with functional outcome and recovery trajectories after thrombectomy: Post-hoc analysis of the ESCAPE-NA1 Trial. Neurology 2023;17 doi:10.1212/WNL.0000000000207700 pmid:37591777

    Abstract/FREE Full Text